Omega-3 review reports fewer infections after colorectal cancer surgery
Pooled randomized trials favored supplementation for several postoperative outcomes. Mortality differences were statistically inconclusive, and the abstract does not quantify the recovery benefits.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Among people having colorectal cancer surgery, supplementation was associated with fewer infectious complications and shorter hospitalization in pooled randomized trials. Mortality did not show a statistically significant difference between groups. The results suggest possible recovery benefits in this surgical setting, while leaving their size and any survival effect uncertain.
The abstract supplies significance tests without effect sizes or follow-up lengths. Its proposed dose range came from a post hoc analysis, whose supporting details are not available here.
What researchers found
Postoperative infectious complications
Supplementation versus trial controls after surgery; exact follow-up duration and effect size are not reported.
Laboratory and clinical outcomes
The review also reported higher protein and albumin levels, changes in immune measures and lower inflammatory markers. These laboratory findings sit alongside the reported surgical outcomes; they are not themselves measures of survival.
Uncertain differences
White blood cells, transcription factor activity and intestinal cell proliferation showed no statistically significant group differences. Together with the mortality result, these findings mean benefits were not statistically demonstrated for those outcomes. They do not establish an absence of benefit.
The original publication
The Role of Omega-3 Polyunsaturated Fatty Acid Supplementation in Postoperative Recovery of Colorectal Cancer: Systematic Review and Meta-Analysis.
Li H, Xu Z, Chen Y et al.
Nutrients · 2026
- PubMed ID
- 41515289
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.